Sunday 22.09.2024 ΚΕΡΚΥΡΑ

Corfu Hospital ready to start vaccinations

coronavirus
02 Jan 2021 / 10:41

CORFU. It was initially announced that vaccinations for the hospital personnel would begin on Monday 4 January. This may well happen but the latest directions are still being awaited - possibly during the weekend.

This is what the hospital administration told Enimerosi. Everything has been prepared so that they can begin innoculating the doctors and other health workers as soon as the vaccines arrive.

This could happen any day now according to the Health Ministry schedule.

It was initially announced that vaccinations for the hospital personnel in Corfu would begin on Monday 4 January. This may well happen, the hospital told Enimerosi, but the latest directions are still being awaited - possibly during the weekend.

As was previously announced, the reference hospitals, which are under the greatest pressure, have priority. Other hospitals in Athens and throughout the country will follow.

Everything depends on the distribution of the vaccines. According to the initial plan and following the first 83,850 Pfizer vaccines to arrive, the European distribution agreement provides for another 429,000 vaccines to arrive by the end of January and a further 333,450 by the end of February.

By the end of March 1,265,550 vaccines are expected from one company - Pfizer/BioNTech. It is expected, however, that once they are approved, vaccines from Moderna and AstraZeneca will be added during January.

Meanwhile, according to the German magazine Spiegel, BioNTech is warning that more vaccines are required.

BioNTech chief executive Uğur Şhin is warning that if other coronavirus vaccines are not immediately approved in Europe, his company alone will not be able to cover all the needs.

"The situation is not rosy," he said in an interview with the German magazine. "There is a gap due to the fact that other vaccines have not been approved and we have to cover this gap with ours."

German Health Minister Jens Spahn has taken immediate steps so that the vaccine developed by Oxford University and AstraZeneca can be approved quickly - but when this will happen still remains uncertain.